Skip to content

Actigraphy as a new objective measure for apathy in schizophrenia

Actigraphy as a new objective measure for apathy in schizophrenia - Actigraphy and Apathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49082
Enrollment
80
Registered
2017-06-06
Start date
2017-07-21
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

apathy listlessness psychosis

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients: - At least 18 y.o.a. - Diagnosis schizophrenia - Maximum score AES (27) - Stable medication use (at least 4 weeks prior to inclusion) - Written informed consent - Participants should have a normal level of exercise tolerance and no physical handicaps that limit their radius of action - Participants should have weekends, wherein they are free from work (i.e. do not have to work weekend shifts), Healthy subjects: - At least 18 y.o.a. - Maximum score AES (27) - Written informed consent - Participants should have a normal level of exercise tolerance and no physical handicaps that limit their radius of action - Participants should have weekends, wherein they are free from work (i.e. do not have to work weekend shifts)

Exclusion criteria

Exclusion criteria: Patients: - An apathy score above 27 on the apathy subscale of the AES-C - Current disorder of substance abuse (excluding nicotine addiction) - Insufficient Dutch language abilities, Healthy subjects: - History of or current psychiatric or neurological illness - An apathy score above 27 on the apathy subscale of the AES-S - Insufficient Dutch language abilities

Design outcomes

Primary

MeasureTime frame
The main study parameters are activity level (Acti-meter) and the degree of apathy (AES).

Secondary

MeasureTime frame
Secondary study parameters are negative symptoms, general psychopathology, depression and the ability to experience pleasure (PANSS, SANS, CDSS and TEPS).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)